Over the past 12 months, 4 insiders at MBX Biosciences, Inc. filed 7 open-market SEC Form 4 transactions on MBX: 4 purchases worth $13.1M and 3 sales worth $2.7M. Insiders have been mixed over this period. The most recent filing was on May 8, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 8, 26 | Salomon AzoulayChief Medical Officer | SELL | 55.0K | $38.38 | $2.1M |
| May 6, 26 | Salomon AzoulayChief Medical Officer | SELL | 231 | $29.54 | $7K |
| Mar 13, 26 | P. Kent HawrylukPresident & CEO | BUY | 18.5K | $28.41 | $526K |
| Oct 20, 25 | P. Kent HawrylukPresident & CEO | BUY | 20.0K | $13.64 | $273K |
| Oct 17, 25 | Steven L. HoerterDirector | BUY | 20.0K | $13.25 | $265K |
| Sep 26, 25 | L.p. Fhmls XTenPercentOwner | BUY | 666.7K | $18.00 | $12.0M |
| Apr 8, 25 | Ora H. PescovitzDirector | BUY | 7.7K | $5.89 | $45K |
| Feb 18, 25 | Carl L GordonDirector,TenPercentOwner | BUY | 94.1K | $10.84 | $1.0M |
| Feb 18, 25 | Orbimed Genesis Gp LlcDirector,TenPercentOwner | BUY | 94.1K | $10.84 | $1.0M |
| Feb 14, 25 | Carl L GordonDirector,TenPercentOwner | BUY | 29.5K | $9.90 | $291K |
| Feb 14, 25 | Orbimed Genesis Gp LlcDirector,TenPercentOwner | BUY | 29.5K | $9.90 | $291K |
| Feb 4, 25 | P. Kent HawrylukPresident & CEO | BUY | 50.0K | $10.69 | $535K |
| Sep 16, 24 | Tiba AynechiDirector | BUY | 750.0K | $16.00 | $12.0M |
| Sep 16, 24 | Forest BaskettTenPercentOwner | BUY | 500.0K | $16.00 | $8.0M |
| Sep 16, 24 | Ali BehbahaniTenPercentOwner | BUY | 500.0K | $16.00 | $8.0M |
| Sep 16, 24 | Carmen ChangTenPercentOwner | BUY | 500.0K | $16.00 | $8.0M |
| Sep 16, 24 | L.p. Fhmls XTenPercentOwner | BUY | 625.0K | $16.00 | $10.0M |
| Sep 16, 24 | Anthony A. Florence Jr.TenPercentOwner | BUY | 500.0K | $16.00 | $8.0M |
| Sep 16, 24 | Carl L GordonDirector,TenPercentOwner | BUY | 500.0K | $16.00 | $8.0M |
| Sep 16, 24 | Patrick J HeronDirector,TenPercentOwner | BUY | 625.0K | $16.00 | $10.0M |
| Sep 16, 24 | Mohamad MakhzoumiTenPercentOwner | BUY | 500.0K | $16.00 | $8.0M |
| Sep 16, 24 | Edward T MathersDirector,TenPercentOwner | BUY | 500.0K | $16.00 | $8.0M |
| Sep 16, 24 | Nea Partners 17, L.p.TenPercentOwner | BUY | 500.0K | $16.00 | $8.0M |
| Sep 16, 24 | Orbimed Advisors LlcDirector,TenPercentOwner | BUY | 500.0K | $16.00 | $8.0M |
| Sep 16, 24 | Scott D SandellTenPercentOwner | BUY | 500.0K | $16.00 | $8.0M |
| Sep 16, 24 | Paul Edward WalkerTenPercentOwner | BUY | 500.0K | $16.00 | $8.0M |
| Sep 16, 24 | Rick YangTenPercentOwner | BUY | 500.0K | $16.00 | $8.0M |
Over the past 12 months, insiders at MBX Biosciences, Inc. filed 4 open-market purchases worth $13.1M and 3 sales worth $2.7M on MBX, which makes them mixed over the period. The most recent Form 4 was filed on May 8, 26.
The largest recent open-market MBX insider purchase in our data was $12.0M by Tiba Aynechi, Director, filed on Sep 16, 24.
4 different insiders at MBX Biosciences, Inc. filed open-market SEC Form 4 transactions on MBX over the last 12 months.
InsiderTape plots every MBX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every MBX Biosciences, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →